These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 12414409)
1. Trehalose eye drops in the treatment of dry eye syndrome. Matsuo T; Tsuchida Y; Morimoto N Ophthalmology; 2002 Nov; 109(11):2024-9. PubMed ID: 12414409 [TBL] [Abstract][Full Text] [Related]
2. Trehalose versus hyaluronan or cellulose in eyedrops for the treatment of dry eye. Matsuo T Jpn J Ophthalmol; 2004; 48(4):321-7. PubMed ID: 15295655 [TBL] [Abstract][Full Text] [Related]
3. A randomized, controlled study of the efficacy and safety of a new eyedrop formulation for moderate to severe dry eye syndrome. Chiambaretta F; Doan S; Labetoulle M; Rocher N; Fekih LE; Messaoud R; Khairallah M; Baudouin C; Eur J Ophthalmol; 2017 Jan; 27(1):1-9. PubMed ID: 27445067 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial. Matsumoto Y; Ohashi Y; Watanabe H; Tsubota K; Ophthalmology; 2012 Oct; 119(10):1954-60. PubMed ID: 22739038 [TBL] [Abstract][Full Text] [Related]
5. Randomized, Multicenter, Double-Blind Study of the Safety and Efficacy of 1%D-3-Hydroxybutyrate eye drops for Dry Eye Disease. Kawakita T; Uchino M; Fukagawa K; Yoshino K; Shimazaki S; Toda I; Tanaka M; Arai H; Sakatani K; Hata S; Okano T; Tsubota K Sci Rep; 2016 Feb; 6():20855. PubMed ID: 26865350 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group. Stevenson D; Tauber J; Reis BL Ophthalmology; 2000 May; 107(5):967-74. PubMed ID: 10811092 [TBL] [Abstract][Full Text] [Related]
7. A Randomized, Placebo-Controlled Phase II Clinical Trial of 0.01% or 0.02% Cyclosporin A with 3% Trehalose in Patients with Dry Eye Disease. Shin J; Rho CR; Hyon JY; Chung TY; Yoon KC; Joo CK J Ocul Pharmacol Ther; 2021; 37(1):4-11. PubMed ID: 33449860 [No Abstract] [Full Text] [Related]
9. Rebamipide (OPC-12759) in the treatment of dry eye: a randomized, double-masked, multicenter, placebo-controlled phase II study. Kinoshita S; Awamura S; Oshiden K; Nakamichi N; Suzuki H; Yokoi N; Ophthalmology; 2012 Dec; 119(12):2471-8. PubMed ID: 23009892 [TBL] [Abstract][Full Text] [Related]
10. The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study. Kojima T; Ishida R; Dogru M; Goto E; Matsumoto Y; Kaido M; Tsubota K Am J Ophthalmol; 2005 Feb; 139(2):242-6. PubMed ID: 15733983 [TBL] [Abstract][Full Text] [Related]
11. Trehalose/sodium hyaluronate eye drops in post-cataract ocular surface disorders. Cagini C; Torroni G; Mariniello M; Di Lascio G; Martone G; Balestrazzi A Int Ophthalmol; 2021 Sep; 41(9):3065-3071. PubMed ID: 33956256 [TBL] [Abstract][Full Text] [Related]
12. Thymosin β4 significantly improves signs and symptoms of severe dry eye in a phase 2 randomized trial. Sosne G; Dunn SP; Kim C Cornea; 2015 May; 34(5):491-6. PubMed ID: 25826322 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of 0.3% carbomer gel compared to placebo in patients with moderate-to-severe dry eye syndrome. Sullivan LJ; McCurrach F; Lee S; Taylor HR; Rolando M; Marechal-Courtois C; Creuzot-Garcher C; Easty DL; Karabatsas C; Bingh Hoh M; Faschinger C; Laroche L Ophthalmology; 1997 Sep; 104(9):1402-8. PubMed ID: 9307633 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of retinol palmitate ophthalmic solution in the treatment of dry eye: a Japanese Phase II clinical trial. Toshida H; Funaki T; Ono K; Tabuchi N; Watanabe S; Seki T; Otake H; Kato T; Ebihara N; Murakami A Drug Des Devel Ther; 2017; 11():1871-1879. PubMed ID: 28694687 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the clinical course of dry eye syndrome. Horwath-Winter J; Berghold A; Schmut O; Floegel I; Solhdju V; Bodner E; Schwantzer G; Haller-Schober EM Arch Ophthalmol; 2003 Oct; 121(10):1364-8. PubMed ID: 14557170 [TBL] [Abstract][Full Text] [Related]
16. Clinical Effects and Safety of 3% Diquafosol Ophthalmic Solution for Patients With Dry Eye After Cataract Surgery: A Randomized Controlled Trial. Park DH; Chung JK; Seo DR; Lee SJ Am J Ophthalmol; 2016 Mar; 163():122-131.e2. PubMed ID: 26685791 [TBL] [Abstract][Full Text] [Related]